Meloxicam and Rheumatic fever - a phase IV clinical study of FDA data
Rheumatic fever is found among people who take Meloxicam, especially for people who are female, 40-49 old.
The phase IV clinical study analyzes which people take Meloxicam and have Rheumatic fever. It is created by eHealthMe based on reports of 55,060 people who have side effects when taking Meloxicam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
55,060 people reported to have side effects when taking Meloxicam.
Among them, 109 people (0.2%) have Rheumatic fever.
What is Meloxicam?
Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 52,561 Meloxicam users for its effectiveness, alternative drugs and more.
What is Rheumatic fever?
Rheumatic fever (an inflammatory disease that occurs following a streptococcus pyogenes infection) is found to be associated with 373 drugs and 196 conditions by eHealthMe.
Number of Meloxicam and Rheumatic fever reports submitted per year:
Gender of people who have Rheumatic fever when taking Meloxicam*:
Age of people who have Rheumatic fever when taking Meloxicam *:
Common drugs people take besides Meloxicam *:
Common side effects people have besides Rheumatic fever *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Meloxicam and have Rheumatic fever?Check whether Rheumatic fever is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How severe was Rheumatic fever and when was it recovered:
Expand to all the drugs that have ingredients of meloxicam:
Alternative drugs to, pros and cons of Meloxicam:
- Meloxicam (52,561 reports)
Common Meloxicam side effects:
Browse all side effects of Meloxicam:a b c d e f g h i j k l m n o p q r s t u v w x y z
Rheumatic fever treatments and more:
- Rheumatic fever (938 reports)
COVID vaccines that are related to Rheumatic fever:
- Rheumatic fever in Moderna COVID Vaccine
- Rheumatic fever in Pfizer BioNTech Covid Vaccine
- Rheumatic fever in Johnson and Johnson Covid Vaccine
Common drugs associated with Rheumatic fever:
All the drugs that are associated with Rheumatic fever:
- Rheumatic fever (373 drugs)
Common conditions associated with Rheumatic fever:
All the conditions that are associated with Rheumatic fever:
- Rheumatic fever (196 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam (the active ingredients of Meloxicam) and Meloxicam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamins and Minastrin 24 Fe drug interaction - 3 seconds ago
- Tyrosine and Claritin drug interaction - 8 seconds ago
- Cellcept and Wellbutrin drug interaction - 10 seconds ago
- Rabeprazole Sodium and Ventavis drug interaction - 13 seconds ago
- Ampyra and Zafirlukast drug interaction - 25 seconds ago
- Lopressor and Atherosclerosis - 42 seconds ago
- Metformin and Device Failure - 49 seconds ago
- Zarxio and Ampyra drug interaction - 51 seconds ago
- Ticlopidine Hydrochloride and Blood Creatine Phosphokinase Mb Increased - a minute ago
- Folate Deficiency and Urination - Painful - a minute ago